CanadaI-131 Diagnostic Capsules (30 μCi and 100 μCi; lots D100-20251001-PNK9, D030-20251001-PNK1) and I-131 Therapeutic Capsule (lot M-20251007-028) from Isologic Innovative Radiopharmaceuticals are affected; check the lot number on the capsule label to recognise affected product. The products were recalled because affected lots are labelled with an incorrect expiry date; verify whether your product is affected, consult your healthcare provider before discontinuing use, contact the recalling firm with questions, and report any side effects or other safety complaints to Health Canada.
What's being recalled
Depth of recall: Healthcare Establishments
Companies: Isologic Innovative Radiopharmaceuticals, 5450 Harvester Road, Burlington, Ontario L7L 5N5.
How to identify it
Brand: Isologic Innovative Radiopharmaceuticals; Product Name: I-131 Diagnostic Capsule; Market Authorization: Not Applicable; Dosage Form: Capsule; Strength: 30uCi & 100uCi; Lot: D100-20251001-PNK9, D030-20251001-PNK1
Brand: Isologic Innovative Radiopharmaceuticals; Product Name: I-131 Therapeutic Capsule; Market Authorization: Not Applicable; Dosage Form: Capsule; Strength: I-131 Therapeutic Capsule; Lot: M-20251007-028
The hazard
Affected lots are labelled with the incorrect expiry date found on the label.
What to do
Verify if your product is affected.
Consult your healthcare provider prior to discontinuing use of the affected product(s), or for any health concerns.
Contact the recalling firm if you have any questions about the recall.
Report any health product related side effects to Health Canada.
Report any other health product safety complaints to Health Canada.
The official notice
This page is a summary of the notice published by Health Canada, collected from Health Canada, CFIA and Transport Canada. Check the original before you act on it.
Read the official notice (opens in a new tab)